Trinity Biotech (TRIB) Other financing activities (2023 - 2024)
Trinity Biotech's (TRIB) quarterly Other financing activities came in at $114.0 in Q2 2024, down 88.31% year-on-year from $975.0 in Q3 2023, and down 85.96% quarter-over-quarter from $812.0 in Q1 2024.
Trinity Biotech (TRIB) Other financing activities (2023 - 2024) Analysis & Trends
Trinity Biotech has disclosed Other financing activities across 2 years of filings, most recently posting $114.0 for Q2 2024.
- Other financing activities for Q2 2024 came in at $114.0, down 88.31% year-over-year; the trailing twelve-month figure through Jun 2024 was $3265.0 (changed N/A YoY), and the FY2021 annual result was -$848.0, changed N/A from the prior year.
- Other financing activities came in at $114.0 for Q2 2024 at Trinity Biotech, down from $812.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1364.0 in Q1 2023 to a low of $114.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 23,520.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 114.00 |
| Jun 30, 2024 | 114.00 |
| Mar 31, 2024 | 812.00 |
| Mar 31, 2024 | 812.00 |
| Jun 30, 2023 | 975.00 |
| Jun 30, 2023 | 975.00 |
| Mar 31, 2023 | 1,364.00 |
| Mar 31, 2023 | 1,364.00 |